Trial intelligence / Profile preview

LEDoxy Ghana

ISRCTN14042737Phase 2Completed

Sponsor
Kumasi Centre for Collaborative Research in Tropical Medicine
Start
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of doxycycline in filariasis (3 arms), sponsored by Kumasi Centre for Collaborative Research in Tropical Medicine. Primary endpoint: Lack of progression of lymphedema. Started Mar 2018; status: completed.

02

Drugs

doxycycline
03

Conditions

filariasis

Beyond the preview

Go deeper on ISRCTN14042737.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN14042737.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call